Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Research on the Individualized Treatment Strategy for Extremely Preterm Infants With hsPDA Based on Biomarkers and Targeted Delivery Systems

NCT07374146 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT07374146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07374146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Research on the Individualized Treatment Strategy for Extremely Preterm Infants With hsPDA Based on Biomarkers and Targeted Delivery Systems
Lead sponsor
Peking University Third Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
February 1, 2026
Completion date
December 31, 2028
Enrollment
80 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hemodynamically significant patent ductus arteriosus